Private equity firm Blackstone is believed to be in talks over a funding deal with the carbon trading platform Xpansiv after it shelved its $2bn float plans.
Xpansiv was planning to list on the ASX with the hope of a $2bn market valuation, but the volatile conditions have meant that has not been able to become a reality. Making matters particularly challenging for the company was the debut of gold mining analysis firm Chrysos on May 6 where its shares fell more than 36 per cent on the first day.
Xpansiv had been relying on its $590m initial public offering to fund the acquisition of the remaining interest in APX that it does not already own.
In March Xpansiv agreed to buy the US-based energy and environmental markets registry infrastructure business for at least $US300m ($418m) in a deal where it initially would secure 20 per cent before acquiring the rest later this year.
Now it is understood Xpansiv is in talks with Blackstone about financing the business.
Consortium forming to make play for Brookfield’s Healthscope
Healthscope remains in the emergency room, but HMC Capital’s backer and industry groups want to offer the hospital provider a lifeline.
Is it third time the charm for Star equity raising?
There’s talk Star Entertainment once again has an equity raising on its agenda.